Over the years, SCiAN has partnered with numerous emerging biotechnology companies throughout key stages of clinical development. Several of these organizations have successfully advanced to acquisition, licensing, or strategic partnership with global pharmaceutical companies. Our continued involvement following these transitions reflects the trust our clients place in our expertise, quality, and long-term commitment to their programs.
Why SCiAN?
Sponsors choose SCiAN for our combination of scientific rigor, operational excellence, and long-term partnership.